Table 2. Patient Characteristics.
| N = 9 | |
|---|---|
| Age (years) | 70.0 (66.0 - 76.0) |
| Male (n) | 6 |
| CVD at the beginning for CR | |
| Status post mitral valve plasty (n) | 2 |
| Status post coronary artery bypass (n) | 1 |
| Angina pectoris(n) | 3 |
| Peripheral artery disease (n) | 3 |
| Metabolic comorbidities | |
| Hypertension (n) | 8 |
| Dyslipidemia (n) | 6 |
| Diabetes mellitus (n) | 4 |
| Hemodialysis (n) | 2 |
| Physical and function status | |
| BMI (kg/m2) | 22.6 (19.9 - 27.3) |
| Rest heart rate (bpm) | 75 (66 - 82) |
| Systolic blood pressure (mm Hg) | 121 (115 - 130) |
| Diastolic blood pressure (mm Hg) | 72 (65 - 76) |
| Peak exercise tolerance (mL/kg/min) | 19.5 (16.7 - 20.2) |
| Ejection fraction (%) | 72 (61.5 - 74.5) |
| Metabolic status | |
| Hemoglobin A1c (%) | 6.7 (6.1 - 7.3) |
| Low-density lipoprotein (mg/dL) | 75 (72 - 97) |
| High-density lipoprotein (mg/dL) | 42 (39 - 52) |
| Triglycerides (mg/dL) | 106 (102 - 115) |
| NT-proBNP (pg/dL) | 182.5 (142.0 - 226.5) |
Data are presented as the median (interquartile range), or as n. BMI: body mass index; CVD: cardiovascular disease; CR: cardiac rehabilitation; NT-proBNP: N-terminal pro-brain natriuretic peptide.